Registry Data Suggests DES Should Be Used Judiciously – Former ACC Head
This article was originally published in The Gray Sheet
Executive Summary
Drug-eluting stents are not appropriate for all coronary disease patients, even though "real-world" registry data suggests the devices reduce target vessel revascularization across almost every patient subgroup, according to presenters at the recent CRT 2004 symposium in Washington, D.C